← All trials
NCT03812900
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2018
- Primary completion
- May 31, 2019
- Completion date
- May 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 400
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bioforce AGLead sponsor
- Cantonal Hospital of St. GallenCollaborator
- Labormedizinisches Zentrum Dr. RischCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.